
	Home Site Map Contact Links Medical News

who is most effected by asthma

Generics at fraction of the cost. Asthma.
Over 500 generics in stock. Licensed online pharmacy. No prescription needed. 10% rebate on reorders. Orders can be tracked online.
Generic medication Low prices
Generic medication from Licensed online pharmacy FREE doctors consultation SAVE up to 70%
ACCOLATE: Find More Information here
Get best results for accolate. Get 10 most relevant accolate results.
Pharmacy online
Legal Only! No RX. TOP 5 Online Pharmacy.
Buy Tramadol Online!
Tramadol. Offer review from dozens of shops. Daily list of the hottest offers on tramadol.
Looking for Accolate?
BizRate helps solve all your shopping needs!
Looking For Cheap Viagra??
Compare Prices For Viagra In Top 10 Online DrugStores. Daily Updated!
Accolate
LowPriceShopper for all your shopping needs!
Accolate
LowPriceShopper for all your shopping needs!
Find accolate
Looking for accolate? Review and compare FindStuff's comprehensive resources.

who is most effected by asthma
DESCRIPTION
Zafirlukast is a synthetic, selective peptide leukotriene receptor antagonist(LTRA), with the chemical name 4-(5-cyclopentyloxy-carbonylamino-1-methyl-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide who is most effected by asthma. The molecular weight of zafirlukast is 575.7 and the structural formula is:

The empirical formula is: C 31 H 33 N 3 O 6 S

Zafirlukast, a fine white to pale yellow amorphous powder, is practically insolublein water who is most effected by asthma. It is slightly soluble in methanol and freely soluble in tetrahydrofuran,dimethylsulfoxide, and acetone who is most effected by asthma.

ACCOLATE is supplied as 10 and 20 mg tablets for oral administration who is most effected by asthma.

Inactive Ingredients: Film-coated tablets containing croscarmellose sodium,lactose, magnesium stearate, microcrystalline cellulose, povidone, hypromellose,and titanium dioxide who is most effected by asthma.

CLINICAL PHARMACOLOGY
Mechanism of Action
Zafirlukast is a selective and competitive receptor antagonist of leukotrieneD 4 and E 4 (LTD 4 and LTE 4 ), components of slow-reacting substance of anaphylaxis(SRSA) who is most effected by asthma. Cysteinyl leukotriene production and receptor occupation have been correlatedwith the pathophysiology of asthma, including airway edema, smooth muscle constriction,and altered cellular activity associated with the inflammatory process, whichcontribute to the signs and symptoms of asthma who is most effected by asthma. Patients with asthma were foundin one study to be 25-100 times more sensitive to the bronchoconstricting activityof inhaled LTD 4 than nonasthmatic subjects who is most effected by asthma.

In vitro studies demonstrated that zafirlukast antagonized the contractileactivity of three leukotrienes (LTC 4 , LTD 4 and LTE 4 ) in conducting airwaysmooth muscle from laboratory animals and humans who is most effected by asthma. Zafirlukast prevented intradermalLTD 4 -induced increases in cutaneous vascular permeability and inhibited inhaledLTD 4 -induced influx of eosinophils into animal lungs who is most effected by asthma. Inhalational challengestudies in sensitized sheep showed that zafirlukast suppressed the airway responsesto antigen; this included both the early- and late-phase response and the nonspecifichyperresponsiveness who is most effected by asthma.

In humans, zafirlukast inhibited bronchoconstriction caused by several kindsof inhalational challenges who is most effected by asthma. Pretreatment with single oral doses of zafirlukastinhibited the bronchoconstriction caused by sulfur dioxide and cold air in patientswith asthma who is most effected by asthma. Pretreatment with single doses of zafirlukast attenuated the early-and late-phase reaction caused by inhalation of various antigens such as grass,cat dander, ragweed, and mixed antigens in patients with asthma who is most effected by asthma. Zafirlukastalso attenuated the increase in bronchial hyperresponsiveness to inhaled histaminethat followed inhaled allergen challenge who is most effected by asthma.

Clinical Pharmacokinetics and Bioavailability:
Absorption
Zafirlukast is rapidly absorbed following oral administration who is most effected by asthma. Peak plasma concentrationsare generally achieved 3 hours after oral administration who is most effected by asthma. The absolute bioavailabilityof zafirlukast is unknown who is most effected by asthma. In two separate studies, one using a high fat andthe other a high protein meal, administration of zafirlukast with food reducedthe mean bioavailability by approximately 40% who is most effected by asthma.

Distribution
Zafirlukast is more than 99% bound to plasma proteins, predominantly albumin who is most effected by asthma. The degree of binding was independent of concentration in the clinically relevantrange who is most effected by asthma. The apparent steady-state volume of distribution (V SS /F) is approximately70 L, suggesting moderate distribution into tissues who is most effected by asthma. Studies in rats using radiolabeledzafirlukast indicate minimal distribution across the blood-brain barrier who is most effected by asthma.

Metabolism
Zafirlukast is extensively metabolized who is most effected by asthma. The most common metabolic products arehydroxylated metabolites which are excreted in the feces who is most effected by asthma. The metabolites ofzafirlukast identified in plasma are at least 90 times less potent as LTD 4receptor antagonists than zafirlukast in a standard in vitro test of activity who is most effected by asthma. In vitro studies using human liver microsomes showed that the hydroxylated metabolitesof zafirlukast excreted in the feces are formed through the cytochrome P4502C9 (CYP2C9) pathway who is most effected by asthma. Additional in vitro studies utilizing human liver microsomesshow that zafirlukast inhibits the cytochrome P450 CYP3A4 and CYP2C9 isoenzymesat concentrations close to the clinically achieved total plasma concentrations(see Drug Interactions ) who is most effected by asthma.

Excretion
The apparent oral clearance (CL/f) of zafirlukast is approximately 20 L/h who is most effected by asthma. Studiesin the rat and dog suggest that biliary excretion is the primary route of excretion who is most effected by asthma. Following oral administration of radiolabeled zafirlukast to volunteers, urinaryexcretion accounts for approximately 10% of the dose and the remainder is excretedin feces who is most effected by asthma. Zafirlukast is not detected in urine who is most effected by asthma.

In the pivotal bioequivalence study, the mean terminal half-life of zafirlukastis approximately 10 hours in both normal adult subjects and patients with asthma who is most effected by asthma. In other studies, the mean plasma half-life of zafirlukast ranged from approximately8 to 16 hours in both normal subjects and patients with asthma who is most effected by asthma. The pharmacokineticsof zafirlukast are approximately linear over the range from 5 mg to 80 mg who is most effected by asthma. Steady-stateplasma concentrations of zafirlukast are proportional to the dose and predictablefrom single-dose pharmacokinetic data who is most effected by asthma. Accumulation of zafirlukast in the plasmafollowing twice-daily dosing is approximately 45% who is most effected by asthma.

The pharmacokinetic parameters of zafirlukast 20 mg administered as a singledose to 36 male volunteers are shown with the table below who is most effected by asthma.

Mean (% Coefficient of Variation) pharmacokinetic
parameters of zafirlukast following single 20 mg
oral dose administration to male volunteers (n=36) C max
ng/mL t max h AUC
ng·h/mL t 1/2
h CL/f
L/h
326 (31.0) 2 (0.5-5.0) 1137 (34) 13.3 (75.6) 19.4 (32)
1 Median and range

Special Populations
Gender: The pharmacokinetics of zafirlukast are similar in males and females who is most effected by asthma. Weight-adjusted apparent oral clearance does not differ due to gender who is most effected by asthma.

Race: No differences in the pharmacokinetics of zafirlukast due to race havebeen observed who is most effected by asthma.

Elderly: The apparent oral clearance of zafirlukast decreases with age who is most effected by asthma. Inpatients above 65 years of age, there is an approximately 2-3 fold greater Cmax and AUC compared to young adult patients who is most effected by asthma.

Children: Following administration of a single 20 mg dose of zafirlukast to20 boys and girls between 7 and 11 years of age, and in a second study, to 29boys and girls between 5 and 6 years of age, the following pharmacokinetic parameterswere obtained:

Parameter Children age
5-6 years
Mean (% Coefficient
of Variation) Children age
7-11 years
Mean (% Coefficient
of Variation)
C max (ng/mL) 756 (39%) 601 (45%)
AUC (ng·h/mL) 2458 (34%) 2027 (38%)
t max (h) 2.1 (61%) 2.5 (55%)
CL/f (L/h) 9.2 (37%) 11.4 (42%)

Weight unadjusted apparent clearance was 11.4 L/h (42%) in the 7-11 year oldchildren and 9.2 L/h (37%) in the 5-6 year old children, which resulted in greatersystemic drug exposures than that obtained in adults for an identical dose who is most effected by asthma. To maintain similar exposure levels in children compared to adults, a dose of10 mg twice daily is recommended in children 5-11 years of age (see DOSAGE ANDADMINISTRATION ) who is most effected by asthma.

Zafirlukast disposition was unchanged after multiple dosing (20 mg twice daily)in children and the degree of accumulation in plasma was similar to that observedin adults who is most effected by asthma.

Hepatic Insufficiency: In a study of patients with hepatic impairment (biopsy-provencirrhosis), there was a reduced clearance of zafirlukast resulting in a 50-60%greater C max and AUC compared to normal subjects who is most effected by asthma.

Renal Insufficiency: Based on a cross-study comparison, there are no apparentdifferences in the pharmacokinetics of zafirlukast between renally-impairedpatients and normal subjects who is most effected by asthma.

Drug-Drug Interactions
The following drug interaction studies have been conducted with zafirlukast(see PRECAUTIONS , Drug Interactions ) who is most effected by asthma.

Coadministration of multiple doses of zafirlukast (160 mg/day) to steady-statewith a single 25 mg dose of warfarin (a substrate of CYP2C9) resulted in a significantincrease in the mean AUC (+63%) and half-life (+36%) of S-warfarin who is most effected by asthma. The meanprothrombin time increased by approximately 35% who is most effected by asthma. The pharmacokinetics of zafirlukastwere unaffected by coadministration with warfarin who is most effected by asthma.
Coadministration of zafirlukast (80 mg/day) at steady-state with a single doseof a liquid theophylline preparation (6 mg/kg) in 13 asthmatic patients, 18to 44 years of age, resulted in decreased mean plasma concentrations of zafirlukastby approximately 30%, but no effect on plasma theophylline concentrations wasobserved who is most effected by asthma.
Coadministration of zafirlukast (20 mg/day) or placebo at steady-state witha single dose of sustained release theophylline preparation (16 mg/kg) in 16healthy boys and girls (6 through 11 years of age) resulted in no significantdifferences in the pharmacokinetic parameters of theophylline who is most effected by asthma.
Coadministration of zafirlukast dosed at 40 mg twice daily in a single-blind,parallel-group, 3-week study in 39 healthy female subjects taking oral contraceptives,resulted in no significant effect on ethinyl estradiol plasma concentrationsor contraceptive efficacy who is most effected by asthma.
Coadministration of zafirlukast (40 mg/day) with aspirin (650 mg four timesdaily) resulted in mean increased plasma concentrations of zafirlukast by approximately45% who is most effected by asthma.
Coadministration of a single dose of zafirlukast (40 mg) with erythromycin (500mg three times daily for 5 days) to steady-state in 11 asthmatic patients resultedin decreased mean plasma concentrations of zafirlukast by approximately 40%due to a decrease in zafirlukast bioavailability who is most effected by asthma.

wheat allergy mold allergy asthma attack information baby allergies asthma guidelines msg allergy small asthma spacer miniature schnauzer and allergies scholarships for students with asthma coffee allergy what are the symptoms of dog asthma death rate and asthma sulfite allergies msg allergies asthma action plan asthma and allergy foundation of america skin allergy asthma research review allergy therapeutic area baby asthma sulfite allergies phosphate allergies asthma images asthma triggers dairy allergy asthma and ozone allergies to alcohol allergys cat allergy medicine asthma in kids allergies and asthma allergy relief for dogs new asthma medications allergy shots silicofluoride treated water and asthma soy allergy sports asthma allergy care centers virginia allergy treatment sinus allergy symptoms allergy index vitamin c & allergies dust allergies allergy testing procedures nut allergies silicofluoride treated water and asthma asthma care in canada diagnosing and treating asthma gluten allergies allergies in dogs signs of asthma sugar allergies aspirin allergy onion allergy sulfite allergy wine allergies asthma and kids allergy patient asthma in the military living with asthma national allergy asthma plan asthma research allergy information allergy skin rash pictures fruit allergies asthma pathophysiology asthma medication

abilify abraxane accolate accupril accutane acetaminophen aciphex aclovate actifed activase actiza actonel actos aczone adacel adalat adderall adipex advair advate agilect albalon albuterol aldomet alesse aleve alimta allegra aloxi alphagan alprazolam altace altocor alvesco amaryl ambien amiodarone amitriptyline amoxicillin androgel angeliq anidulafungin antabuse antegren anusol apidra apokyn arthrotec asacol aspirin atenolol ativan augmentin avandia avapro avastin avelox axid

wwho is most effected by asthma whho is most effected by asthma whoo is most effected by asthma who is most effected by asthma who iis most effected by asthma who iss most effected by asthma who is most effected by asthma who is mmost effected by asthma who is moost effected by asthma who is mosst effected by asthma who is mostt effected by asthma who is most effected by asthma who is most eeffected by asthma who is most efffected by asthma who is most efffected by asthma who is most effeected by asthma who is most effeccted by asthma who is most effectted by asthma who is most effecteed by asthma who is most effectedd by asthma who is most effected by asthma who is most effected bby asthma who is most effected byy asthma who is most effected by asthma who is most effected by aasthma who is most effected by assthma who is most effected by astthma who is most effected by asthhma who is most effected by asthmma who is most effected by asthmaa ho is most effected by asthma wo is most effected by asthma wh is most effected by asthma whois most effected by asthma who s most effected by asthma who i most effected by asthma who ismost effected by asthma who is ost effected by asthma who is mst effected by asthma who is mot effected by asthma who is mos effected by asthma who is mosteffected by asthma who is most ffected by asthma who is most efected by asthma who is most efected by asthma who is most effcted by asthma who is most effeted by asthma who is most effeced by asthma who is most effectd by asthma who is most effecte by asthma who is most effectedby asthma who is most effected y asthma who is most effected b asthma who is most effected byasthma who is most effected by sthma who is most effected by athma who is most effected by ashma who is most effected by astma who is most effected by astha who is most effected by asthm w ho is most effected by asthma wh o is most effected by asthma who is most effected by asthma who is most effected by asthma who i s most effected by asthma who is most effected by asthma who is most effected by asthma who is m ost effected by asthma who is mo st effected by asthma who is mos t effected by asthma who is most effected by asthma who is most effected by asthma who is most e ffected by asthma who is most ef fected by asthma who is most eff ected by asthma who is most effe cted by asthma who is most effec ted by asthma who is most effect ed by asthma who is most effecte d by asthma who is most effected by asthma who is most effected by asthma who is most effected b y asthma who is most effected by asthma who is most effected by asthma who is most effected by a sthma who is most effected by as thma who is most effected by ast hma who is most effected by asth ma who is most effected by asthm a who is most effected by asthma hwo is most effected by asthma woh is most effected by asthma wh ois most effected by asthma whoi s most effected by asthma who si most effected by asthma who i smost effected by asthma who ism ost effected by asthma who is omst effected by asthma who is msot effected by asthma who is mots effected by asthma who is mos teffected by asthma who is moste ffected by asthma who is most fefected by asthma who is most effected by asthma who is most efefcted by asthma who is most effceted by asthma who is most effetced by asthma who is most effecetd by asthma who is most effectde by asthma who is most effecte dby asthma who is most effectedb y asthma who is most effected yb asthma who is most effected b yasthma who is most effected bya sthma who is most effected by sathma who is most effected by atshma who is most effected by ashtma who is most effected by astmha who is most effected by astham awho is most effected by asthma thewho is most effected by asthma who is most effected by asthma

a b c d e f g h i k l m n o p r s t u v w x z